UCHL1 and pulmonary fibrosis: IMP-1710 a potent and selective UCH-L1 inhibitor which labels C90 of UCH-L1 at nanomolar concentrations in a cell model of idiopathic pulmonary fibrosis, blocking the profibrotic response [142].